MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Heron Therapeutics, Inc.

HRTX

#3001
Heron Therapeutics, Inc.
1.19
-0.83%
Sector:
Base:
Profit Currency:
Daily Range
1.19
1.19
Year Range
1.00
2.68
Daily Change
-0.83%
Monthly Change
-14.39%
6 month change
-11.85%
Year Change
-39.90%
Previous Close
1.20
Open
1.19
Bid
Ask
Low
1.19
High
1.19
Volume
58
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. HRTX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Seeking Alpha Seeking Alpha
HRTX
2 days ago, 20:08
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call Transcript
Investing Investing
HRTX
2 days ago, 16:27
Heron Therapeuti earnings missed, revenue topped estimates
Investing Investing
HRTX
2 days ago, 14:50
Heron Q4 2025 slides: acute care surge drives 48% ZYNRELEF growth
Investing Investing
HRTX
2026.01.09
Heron Therapeutics stock soars after strong Q4 revenue growth
Investing Investing
HRTX
2025.12.04
Heron’s APONVIE featured in new postoperative nausea guidelines
Investing Investing
HRTX
2025.11.04
Jefferies lowers Heron Therapeutics stock price target on oncology franchise decline
Seeking Alpha Seeking Alpha
HRTX
2025.11.04
Heron Therapeutics, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:HRTX) 2025-11-04
Investing Investing
HRTX
2025.11.04
Heron Therapeutics Q3 2025 slides: strong product growth despite earnings miss
Zacks Zacks
HRTX
2025.11.04
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Zacks
HRTX
2025.11.04
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates
Investing Investing
HRTX
2025.10.15
Heron Therapeutics shareholders approve convertible securities issuances
Investing Investing
HRTX
2025.08.15
Heron Therapeutics adopts tax benefits plan to protect $1.37 billion in NOLs

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd